Form 4: Opaleye Management Reduces Stake in SANUWAVE Health

Opaleye Management Inc. reported the sale of 16,469 shares of SANUWAVE Health, Inc. common stock across multiple transactions.

Summary

• Opaleye Management Inc., a 10% owner of SANUWAVE Health, Inc., executed sales of common stock between April 17, 2026, and April 21, 2026.
• A total of 16,469 shares were sold, reducing the beneficial ownership held through Opaleye, L.P. and a managed account.
• The sales were executed at weighted average prices of $20.4611 and $20.5025 per share.
• Following these transactions, the reporting entity maintains a beneficial ownership of 954,798 shares through Opaleye, L.P. and 10,000 shares through a managed account.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; it is a standard regulatory disclosure of routine portfolio management by an institutional investor.

Positives

• The transactions were executed at price points exceeding $20.00 per share, reflecting the current market valuation of the equity.

Negatives

• The reduction in holdings by a 10% owner may be perceived by the market as a lack of long-term confidence or a rebalancing of portfolio risk.

Risks

• Continued divestment by major shareholders could exert downward pressure on the stock price.
• Market volatility may impact the liquidity and pricing of future transactions.

Future Outlook

No specific forward-looking guidance regarding the company's operations or future stock performance was provided in this filing.

Management Comments

• The reporting person undertakes to provide full information regarding the number of shares sold at each price within the reported range upon request.

Industry Context

StockSavvy.ai notes that institutional divestment in small-cap healthcare technology firms like SANUWAVE is often a routine portfolio rebalancing exercise rather than a signal of fundamental operational distress.

Comparison to Industry Standards

• The sale of shares by a 10% owner is a standard regulatory disclosure and aligns with typical institutional investment management practices.
• The transaction volume is relatively minor compared to the total outstanding shares, suggesting limited impact on overall corporate control.

Stakeholder Impact

• Shareholders should note the change in ownership structure, though it does not directly impact company operations.

Next Steps

• Continued monitoring of Form 4 filings to track further changes in institutional ownership.

Key Dates

Keywords

SANUWAVE Health, SNWV, Opaleye Management, Insider Trading, Form 4, Beneficial Ownership